[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341427-105":59,"doc-detail-341427-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","tardbp-is-a-candidate-diagnostic-biomarker-promoting-tumor-progression-via-impacting-tumor-immunity-and-tumor-microenvironment-research-paper","TARDBP is a candidate diagnostic biomarker promoting tumor progression via impacting tumor immunity and tumor microenvironment - Research Paper","","The study examines TAR DNA-binding protein (TARDBP) in cancer research, focusing on hepatocellular carcinoma (HCC), where TARDBP’s abnormal expression links it to oncogenic processes. It describes TARDBP as broadly upregulated across multiple cancers and associated with tumor mutational burden, supporting its role in genomic instability and cancer progression. The work analyzes interactions with immune and inflammatory factors in the tumor microenvironment and reports that TARDBP correlates with adverse clinical outcomes in HCC, suggesting therapeutic targeting potential.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/tardbp-is-a-candidate-diagnostic-biomarker-promoting-tumor-progression-via-impacting-tumor-immunity-and-tumor-microenvironment-research-paper/341427/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/tardbp-is-a-candidate-diagnostic-biomarker-promoting-tumor-progression-via-impacting-tumor-immunity-and-tumor-microenvironment-research-paper/341427.png","ImageObject",300,407,{"name":92,"@type":93},"Noah","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-08","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is TARDBP and why is it relevant to cancer and HCC?","Question",{"text":113,"@type":114},"TARDBP (TAR DNA-binding protein 43/TDP-43) is a nuclear protein regulating gene expression. In HCC it is described as aberrantly expressed and linked to oncogenic processes and tumorigenesis.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does TARDBP relate to tumor progression mechanisms?",{"text":118,"@type":114},"The document states that TARDBP can influence proliferation, apoptosis, metastasis, tumor microenvironment, angiogenesis, and immune escape. It also highlights associations with genomic instability-related features.",{"name":120,"@type":111,"acceptedAnswer":121},"Why is TARDBP considered a potential diagnostic or therapeutic target?",{"text":122,"@type":114},"The abstract reports that TARDBP is upregulated across cancers, correlates with tumor mutational burden, and is associated with adverse outcomes in HCC. These findings support its potential as a diagnostic biomarker and therapeutic target.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},341427,1791180061,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},8796095462418,"https://ap-avatar.wpscdn.com/avatar/80000253c1241d02b47?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778826106357471780","Ivyspring  \nInternational Publisher  \nJournal of Cancer  \n2024; 15(13): 4113-4127. doi: 10.7150/jca.96800  \nResearch Paper  \nTARDBP is a candidate diagnostic biomarker promoting tumor progression via impacting tumor immunity and tumor microenvironment  \nMin-Yi Luo1,2†, Zhe Han3†, Jiaqi Wang4†, Cheng Zhong5􀀍, Jiancong Chen1􀀍  \n1. Department of Pancreato-Biliary Surgery, The First Affiliated Hospital, Sun Yat-sen University, 510080, Guangzhou, Guangdong, China.  \n2. Department of Coloproctology, The Sixth Affiliated Hospital, Sun Yat-sen University, 510080, Guangzhou, Guangdong, China.  \n3. Department of Neurology, The First Bethune Hospital of Jilin University, 130000, Changchun, Jilin, China.  \n4. Department of Neonatology, Jiangmen People's Hospital, 52900, Jiangmen, Guangdong, China.  \n5. Department of Orthopedics, Jiangmen Hospital of Traditional Chinese Medicine Affiliated to Jinan University, 52900, Jiangmen, Guangdong, China.†These authors contributed equally to this work.  \n􀀍 Corresponding authors: Jiancong Chen: [chenjc25@mail.sysu.edu.cn](chenjc25@mail.sysu.edu.cn); [Cheng Zhong: 20216020037@stu.gzucm.edu.cn](Cheng Zhong: 20216020037@stu.gzucm.edu.cn).  \n© The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License ([https://creativecommons.org/licenses/by/4.0/](https://creativecommons.org/licenses/by/4.0/)). See [http://ivyspring.com/terms](http://ivyspring.com/terms) for full terms and conditions.  \nReceived: 2024.03.30; Accepted: 2024.05.23; Published: 2024.06.03  \nAbstract  \nIn the realm of cancer research, particularly hepatocellular carcinoma (HCC), TAR DNA-binding protein (TARDBP) has transitioned from being associated with neurodegenerative diseases to emerging as a significant molecule in oncology due to its aberrant expression in HCC and other malignancies. This shift underlines the versatility of TARDBP and its critical role in tumorigenesis. Our study illuminates TARDBP's universal upregulation across various cancers, indicating its involvement in fundamental oncogenic processes and potential impact on genomic instability. The relationship between TARDBP expression and tumor mutational burden (TMB) across several cancers highlights its influence on a key hallmark of cancer progression. Additionally, TARDBP's interaction with immune and inflammatory factors within the tumor microenvironment, including its association with immune-stimulatory factors and inverse relationship with immune inhibitors, suggests its role in modulating immune evasion. Clinically, TARDBP's aberrant expression correlates with adverse patient outcomes in HCC, making it a promising candidate for therapeutic targeting. The study concludes that TARDBP holds significant potential as a novel therapeutic target in HCC and possibly other malignancies, meriting further exploration to integrate TARDBP-targeted therapies into cancer treatment protocols, thereby advancing the field of precision medicine.  \n1. Introduction  \nTAR DNA-binding protein 43 (TARDBP), also known as TDP-43, is a highly conserved nuclear protein involved in the regulation of gene expression, including roles in RNA splicing, transcriptional repression, and RNA stability [1, 2] . Beyond its well-documented involvement in neurodegenerative diseases, emerging evidence has highlighted the significance of TARDBP in various cancer pathways, indicating its potential as a biomarker for tumor progression and prognosis [3-7] . The protein's aberrant expression and mutations have been  \nassociated with altered cellular dynamics, promoting oncogenesis through the dysregulation of cell proliferation, apoptosis, and metastasis [8-10] . Studies have demonstrated that TARDBP can influence tumor microenvironment, angiogenesis, and immune escape mechanisms, thereby supporting the aggressive behavior of malignant cells [11, 12] . Despite its growing recognition in cancer biology, the comprehensive impact of TARDBP across different can","cbCaiieedCTWqz1K","https://ap.wps.com/l/cbCaiieedCTWqz1K","pdf",8412320,15,"English","# Abstract\n# Introduction","[{\"question\":\"What is TARDBP and why is it relevant to cancer and HCC?\",\"answer\":\"TARDBP (TAR DNA-binding protein 43/TDP-43) is a nuclear protein regulating gene expression. In HCC it is described as aberrantly expressed and linked to oncogenic processes and tumorigenesis.\"},{\"question\":\"How does TARDBP relate to tumor progression mechanisms?\",\"answer\":\"The document states that TARDBP can influence proliferation, apoptosis, metastasis, tumor microenvironment, angiogenesis, and immune escape. It also highlights associations with genomic instability-related features.\"},{\"question\":\"Why is TARDBP considered a potential diagnostic or therapeutic target?\",\"answer\":\"The abstract reports that TARDBP is upregulated across cancers, correlates with tumor mutational burden, and is associated with adverse outcomes in HCC. These findings support its potential as a diagnostic biomarker and therapeutic target.\"}]","TARDBP is a candidate diagnostic biomarker promoting tumor progression via impacting tumor immunity and tumor microenvironment - Research Paper | PDF",1790041856,38,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2d0992e9278e4e0711556644ebcc559a.webp",983,1272,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b7d13f7d4266489e8bc472e22d682dc0.webp",982,1270,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c92b8b680b8a78c06e3649dbcc574af1.webp",981,1269,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/51b37607060857596970bff839cc330c.webp",980,1268]